df-1001
dragonfly
['gamma']
df1001 is a first-in-class immune modulating trinket targeting her2 that drives immune activation in tumors by inducing synergistic activation of nk cells (dual nkg2d &amp; cd16 agonism). cd8+ t cells &amp; gamma delta t-cells also express &amp; respond to nkg2d stimulation in tme #asco23
We are a clinical-stage company developing drugs targeting natural killer cells & other cells of the innate immune system, to eliminate cancer & other diseases.